• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Adv Exp Med Biol . Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation

tetano

Editor, Senior Moderator
Adv Exp Med Biol


. 2022;1395:99-103.
doi: 10.1007/978-3-031-14190-4_17.
Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation


Sebastiano Cicco[SUP] 1 [/SUP], F Albanese[SUP] 2 [/SUP], R Didonna[SUP] 2 [/SUP], A Magistro[SUP] 2 [/SUP], A Vacca[SUP] 3 [/SUP], C Cariddi[SUP] 4 [/SUP], G Lauletta[SUP] 2 [/SUP], F Pappagallo[SUP] 2 [/SUP], A G Solimando[SUP] 2 [/SUP], R Ria[SUP] 2 [/SUP]



Affiliations

Abstract

Background: COVID-19 induces robust systemic inflammation. One of the main complications is the increased coagulation due to endotheliitis. There is an increased incidence of pulmonary embolism (PE) in COVID-19 patients. However, clinical characteristics for a strict analysis are yet to be determined.
Aim: We evaluated oxygenation and characteristics in patients with COVID-19 PE (CPE).
Material and methods: We evaluated 215 COVID-19 patients from 1 January to 30 April 2021. We found 18 patients affected by PE (CPE, 50.0% males, aged 67.00 ± 10.86 years). As controls, we used data from patients affected by PE evaluated in our ward between 1 January 2015 and 31 December 2019 (64 patients, 53.1% males, aged 70.88 ± 16.44 years). All patients underwent a complete physical examination, pulmonary computerised tomography, laboratory tests, D-dimers and blood gas analysis at the time of diagnosis.
Results: There were no differences in laboratory tests nor in D-dimers between the two groups. In the CPE group we found a significantly increased pO[SUB]2[/SUB] (92.83 ± 42.52 vs. 76.11 ± 32.58 mmHg; p < 0.05), difference of oxygen between alveoli and arteries (A-aDO[SUB]2[/SUB]; 169.3 ± 171.9 vs. 52.97 ± 39.65 mmHg; p < 0.05), and oxygen saturation % (97.06 ± 2.59 vs. 93.77 ± 5.53%; p < 0.05) compared to controls. No difference was found in pCO[SUB]2[/SUB] and the ratio between pO[SUB]2[/SUB] and percentage of inspired oxygen (P/F). Finally, a significantly decreased urate (3.67 ± 1.49 vs. 5.60 ± 2.10; p < 0.05) was found in CPE compared to controls. In CPE, platelets count presents an inverse correlation to P/F (r = -0.389, p = 0.02) but a direct correlation to A-aDO[SUB]2[/SUB] (r = 0.699, p = 0.001). No similar findings were present in controls.
Discussion: COVID-19 PE appears to have a different clinical setting. Reduced oxygenation described in PE may not to be considered as a sign of disease. The increased A-aDO[SUB]2[/SUB] may indicate that COVID-19 PE involved smaller vessels compared to classical PE. A possible diffuse capillary thrombosis could explain these results.

Keywords: Endotheliitis; Platelet counts; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2); Systemic inflammation.
 
Back
Top Bottom